For Sacramento, California residents, geographic distance from mainland pharmacies has historically affected access to specialty medications. Zepbound® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly; Pacific-region retail pricing varies by pharmacy. Weight Method offers a separate telehealth program: licensed California providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program is priced at $329/month uniformly, shipped directly to your Sacramento address.
FDA-approved Zepbound prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Sacramento is already seeing results
Zepbound in Sacramento, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Zepbound to patients in Sacramento from $329/month with virtual consultations and direct-to-door shipping.
For many people in Sacramento, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Tirzepatide addresses hormonal drivers involved in body weight regulation. Zepbound® is the FDA-approved Injectable pen Tirzepatide product by Eli Lilly, approved in 2023 for Chronic weight management. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The program is priced at $329/month, including the evaluation, the medication, ongoing care, and home delivery to Sacramento.
In a diverse metropolitan area like Sacramento, healthcare must meet patients where they are — linguistically and culturally. Weight Method prescribes compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy, with full bilingual support in English and Spanish. Compounded Tirzepatide is not FDA-approved. Every patient understands their treatment plan, dosing schedule, and what to expect — this is core to how we deliver care in multicultural metros.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Zepbound from $329/month.
Get Started NowFree consultation. No commitment.